- Zacks•2 days ago
Celgene Corporation (CELG), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.38% last quarter.
- Market Realist•5 days ago
23.1% of analysts gave United Therapeutics (UTHR) a “buy” recommendation while 69.2% of analysts rated the company a “hold.”
United Therapeutics CorporationNasdaqGS
After hours: 113.200.00 (0.00%) as of 4:42 PM EDT
|Bid||113.00 x 100|
|Ask||115.87 x 200|
|52wk Range||97.52 - 172.39|
|Day's Range||111.19 - 114.12|
|Avg Vol (3m)||637,126|
As of 4:00 PM EDT. Market closed.